This review emphasizes that pulmonary hypertension secondary to left-sided heart disease worsens prognosis and should be managed by addressing the underlying cardiac condition.
Answers are grounded in this paper and cite their sources.
Supports treating underlying left heart disease in secondary PH; leaves open targeted therapy trials.
Pulmonary hypertension (PH) is the end result of a variety of diverse pathologic processes. The chronic elevation in pulmonary artery pressure often leads to right ventricular pressure overload and subsequent right ventricular failure. In patients with left-sided cardiac disease, PH is quite common and associated with increased morbidity and mortality. This article will review the literature as it pertains to the epidemiology, pathogenesis, and diagnosis of PH related to aortic valve disease, mitral valve disease, left ventricular systolic and diastolic dysfunction, and pulmonary veno-occlusive disease. Moreover, therapeutic strategies, which focus on treating the underlying cardiac pathology will be discussed.
No takes yet. Share an insight, caveat, or question.
Kiefer et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: